Connect with us

Business

Elixir Energy Limited (ELXPF) Shareholder/Analyst Call – Slideshow

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript
Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

EchoStar Corporation 2026 Q2 – Results – Earnings Call Presentation (NASDAQ:ECHO) 2026-08-03

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

This article was written by

Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts Team

Continue Reading

Business

Managing Regulatory Compliance During the First Year of Operations in Indonesia

Published

on

Managing Regulatory Compliance During the First Year of Operations in Indonesia

Foreign investors face significant regulatory risks during Indonesia market entry, especially in licensing, compliance, and KBLI classifications, affecting growth, operational flexibility, and strategic planning.

Regulatory Risks During Initial Operations

Many foreign investors see incorporation as the final step for entering the Indonesian market. However, the first year of operations often presents the greatest regulatory challenges. During this period, licensing conditions, tax obligations, workforce requirements, governance duties, and reporting responsibilities come into play as businesses start their commercial activities. As companies grow—hiring staff, generating revenue, and establishing new partnerships—compliance shifts from an administrative task to a key strategic factor that impacts expansion, financing, and operational flexibility.

Risks of Diverging from Inception Assumptions

A primary regulatory risk arises when actual commercial activities differ from the assumptions made at incorporation. Indonesia classifies businesses through the KBLI system, which determines licensing needs, foreign ownership limits, and applicable regulations. Companies expanding into new sectors or altering services must ensure their activities still conform to their initial classifications to avoid legal issues and additional regulatory requirements.

Maintaining Compliance and Operational Flexibility

Under Indonesia’s risk-based licensing framework, regulatory obligations depend on activity types and associated risk levels. Businesses may face delays if new ventures require extra approvals, affecting project timelines and profitability. Therefore, strategic planning should incorporate licensing considerations to prevent disruptions caused by regulatory compliance issues, ensuring smooth growth and operational agility.

Advertisement


Read the original article : Managing Regulatory Compliance During the First Year of Operations in Indonesia

Continue Reading

Business

Baidu Shares Advance Nearly 4% Fueled by AI Business Momentum and Dual Listing Progress in Hong Kong

Published

on

Baidu HQ

Baidu Inc. shares rose nearly 4% in Hong Kong trading Monday, extending recent gains as investors focused on the company’s accelerating artificial intelligence businesses, progress toward a dual-primary listing and the approach of its next earnings report.

The stock closed at 109.90 Hong Kong dollars, up 4.00 dollars or 3.78%, after trading as high as 110.50 dollars during the session. The advance came amid broader interest in Chinese technology shares, particularly those with visible AI exposure.

Baidu has increasingly positioned itself as an AI-first company. In its first-quarter results reported in May, the core AI-powered business exceeded half of Baidu General Business revenue for the first time. That segment generated 13.6 billion yuan, a 49% increase from the year-earlier period and accounted for 52% of general business revenue.

“These results confirm that AI has clearly become the primary growth driver of Baidu,” Chief Executive Robin Li said during the earnings discussion. He also noted that the milestone “marking a clear signal that AI has become the core driver of Baidu.”

Advertisement

Within the AI portfolio, AI Cloud Infrastructure revenue rose 79% year over year to 8.8 billion yuan, while GPU cloud revenue accelerated 184%. AI-native marketing services grew 36%. The company has highlighted enterprise demand for training and inference workloads across industries including gaming, financial services, manufacturing and autonomous driving.

Baidu’s Apollo Go robotaxi service continued expanding, delivering 3.2 million fully driverless rides in the first quarter, more than double the prior-year figure. Cumulative rides surpassed 22 million, with operations spanning multiple cities. Recent testing of the sixth-generation autonomous vehicle began in London in partnership with Freenow by Lyft.

The company is also advancing structural initiatives. In July, Baidu received acknowledgment from the Hong Kong Stock Exchange for its application to convert its secondary listing to dual-primary status on the Main Board. The conversion is expected within 2026 pending final approvals and would result in dual-primary listings in Hong Kong and on the Nasdaq. The move aims to deepen access to local investors given the company’s business ties to mainland China and rising Hong Kong trading volumes.

Shareholders will consider related capital mandates at an extraordinary general meeting scheduled for Aug. 26. Proposed resolutions include authority for directors to issue up to 20% additional Class A shares or ADSs and to repurchase up to 10% of outstanding shares, along with adoption of a 2026 share incentive plan and amendments to the articles of association to align with Hong Kong listing rules. Baidu already operates an active share repurchase program, under which it has bought back shares and ADSs in the open market.

Advertisement

The next quarterly results, for the period ended June 30, are scheduled for release on Aug. 18. Analysts will scrutinize the trajectory of AI cloud growth, the pace of advertising stabilization and overall profitability trends. Traditional search and feed advertising has faced pressure from softer consumer spending and structural shifts, though AI-related marketing has provided some offset.

Baidu maintains a substantial cash and investments position exceeding 270 billion yuan as of the first quarter, supporting continued investment in AI infrastructure, chips through its Kunlunxin unit, model development and autonomous driving. The company has emphasized full-stack capabilities spanning chips, models such as the ERNIE series, cloud services and applications including agents and productivity tools.

Market participants have pointed to the shifting revenue mix toward higher-growth AI areas as a key long-term driver, even as near-term margins reflect investment intensity. The dual-listing process and capital flexibility measures are viewed as supporting options for funding growth or returning capital.

Chinese technology shares have shown periods of renewed interest tied to AI developments across the sector. Baidu’s shares have traded in a wide range over the past year, reflecting both the opportunities in AI infrastructure and applications and the challenges in legacy advertising and macroeconomic conditions.

Advertisement

Risks include the speed of traditional advertising recovery, competition in cloud and AI services, execution on autonomous vehicle commercialization, regulatory developments and broader sentiment toward Chinese equities. Geopolitical factors and technology supply chains also remain relevant considerations.

Nevertheless, the combination of demonstrated AI revenue scale, cloud acceleration, autonomous driving progress, listing upgrades and upcoming catalysts contributed to Monday’s advance. Trading volume reflected active participation as the stock moved higher.

Baidu continues to describe AI adoption as accelerating across real-world applications, opening diverse demand for its capabilities. With the dual-primary conversion advancing and earnings approaching, investors are assessing whether the AI-led transition can deliver sustained growth and improved returns. The latest session underscored ongoing market attention to that shift.

Advertisement
Continue Reading

Business

Workers Seeking Compensation for Injuries Face New Challenge: Fewer Lawyers

Published

on

Workers Seeking Compensation for Injuries Face New Challenge: Fewer Lawyers

FARGO, N.D.—Oak Reile was delivering a pallet of washer fluid, cigarettes and candy to a local convenience store in 2020 when he slipped and fell, breaking two vertebrae and paralyzing him from the armpits down.

After months of hospitalization and rehab, Reile slid into a deep depression. Sometimes he would tell his wife, Kirsten, “You should’ve just let me die,” she says. He started seeing a therapist, but the state workers’ compensation agency denied the claim, arguing depression wasn’t a physiological effect of his injury.

The Reiles, frustrated by other denials too, decided to fight. That was when they discovered another hurdle to getting medical bills paid for on-the-job injuries in North Dakota: There are just two lawyers left in the state who will represent injured workers. Both are in their late 60s and plan to retire soon.

The pool of lawyers pursuing workers’ compensation cases is shrinking in some states. State laws have dialed back payouts and benefits enough that young lawyers are turning to more-lucrative specialties, rather than replacing veteran attorneys who are retiring.

Advertisement

Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Continue Reading

Business

North Shields accountants Hurren & Jubb merge with national group Streets

Published

on

Business Live

‘Our team has embraced the transition, and our focus has been on making the process as smooth as possible for our people and our clients’

The Streets North Shields team with director Shaun Jubb, pictured fifth from right.

The Streets North Shields team with director Shaun Jubb, pictured fifth from right.(Image: The Streets)

A Tyneside accountancy practice has joined a growing national advisory group after almost 40 years of trading. North Shields-based Hurren & Jubb Accountants has joined top 40 UK accountancy and advisory practice Streets, and will now trade as Streets Hurren & Jubb.

The Albion Road office was first established in 1988 and has built a reputation for supporting businesses and individuals across North Tyneside and the wider North East. Directors said joining Streets marks the next stage in the firm’s growth.

Shaun Jubb, director at Streets Hurren & Jubb, joined the practice in 2013 and was made director six years later. He said: “As the practice continues to grow, joining a national firm is the natural next step. It allows us to continue providing the personal service our clients value while giving them access to a much broader range of specialist expertise.

“Our team has embraced the transition, and our focus has been on making the process as smooth as possible for our people and our clients.”

Advertisement

Like this story? For more deals news you can visit our dedicated page for the latest news and analysis here.

The merger, which comes four months after Mr Jubb met Streets chairman and CEO Paul Tutin, gives clients immediate access to Streets’ specialist areas including tax relief, tax planning, grants and funding advice, as well as a wider network of technical specialists.

Mr Jubb said he has already seen early benefits for the practice, including boosted HR support, greater assistance with recruitment and access to a broader talent pool to support future growth.

He added: “From our first conversation, Paul was approachable, genuine and down-to-earth. Throughout the process he was always available, supportive and easy to deal with. What you see is what you get, and that gave us confidence we were making the right decision.”

Advertisement

Mr Tutin added: “We are delighted to welcome Shaun and the team to Streets. They have built an excellent reputation through outstanding client service, long-standing relationships and the dedication of an experienced team.

“We look forward to supporting their continued growth and providing clients with access to the wider expertise and resources available across Streets.”

Continue Reading

Business

Micron: The Math Makes No Sense (Rating Upgrade)

Published

on

Micron: The Math Makes No Sense (Rating Upgrade)

Micron: The Math Makes No Sense (Rating Upgrade)

Continue Reading

Business

Arginine Supplement Could Boost Immunity Against Cancer and Viruses by Restoring Key Cell Warning Protein

Published

on

Arginine Supplement Could Boost Immunity Against Cancer and Viruses by

A common amino acid found in protein-rich foods and produced naturally by the body may help the immune system better detect cancer cells and fight viral infections, according to new research from Rockefeller University.

Scientists reported that low levels of arginine impair production of MHC-1, a critical protein that displays abnormal or foreign proteins on cell surfaces so that T cells can recognize threats. Restoring arginine levels, even in moderate amounts comparable to a couple of over-the-counter tablets, appeared to revive expression of the genes needed to make MHC-1.

The findings, published in the journal Cell, stem from work led by Sohail Tavazoie in the Elizabeth and Vincent Meyer Laboratory of Systems Cancer Biology. First author Qiushuang Wu, a postdoctoral researcher in the lab, examined how shifts in amino acid availability affect gene expression.

“Our work reveals how a lack of arginine interferes with the immune system, and suggests that upping arginine intake could prove beneficial,” Wu said. “Perhaps that means it could be used in combination with other therapies to treat both cancer and viral infections.”

Advertisement

Arginine supports protein synthesis and other essential cellular functions. Six different codons encode the amino acid, underscoring its importance. Prior research from the same laboratory showed that depriving colon cancer cells of arginine led them to accumulate more mutations. The new study extends that work by linking arginine scarcity to weakened immune surveillance.

Wu analyzed disease models of colon cancer, influenza and SARS-CoV-2. Across these conditions, arginine emerged as the most depleted amino acid. In cell culture experiments, declining arginine levels reduced the abundance of 414 proteins. Most were connected to known arginine-related pathways, but three HLA genes responsible for MHC-1 production stood out as unexpectedly affected.

MHC-1 proteins act as cellular warning signals. They present fragments of mutated or viral proteins to the immune system. Without sufficient arginine, ribosomes stall while assembling MHC-1 because the protein contains many sites that require the amino acid. As a result, fewer warning signals appear on cell surfaces, allowing potentially dangerous cells to evade detection more readily.

Tavazoie described the broader implication. “These findings are exciting because they reveal that consumption of a specific amino acid can directly regulate gene expression in an organism by increasing production of a protein enriched in that amino acid,” he said. “We believe that such selective translational tuning of gene expression through dietary manipulation likely extends to many other proteins and amino acids.”

Advertisement

Dietary experiments in mice reinforced the laboratory observations. Animals given a low-arginine diet developed more colon tumors. Those receiving higher amounts of arginine developed fewer tumors. Parallel studies with influenza and SARS-CoV-2 models, conducted in collaboration with researchers in Charles Rice’s Laboratory of Virology and Infectious Disease, produced similar patterns.

Mice on arginine-rich diets experienced milder symptoms from the viral infections. Providing arginine after influenza infection also improved outcomes. “Not only did mice with an arginine-rich diet have milder symptoms from viral infections, giving the mice arginine after influenza infection improved their outcomes too,” Wu said. “That was very surprising. From our genetic models, we knew manipulating arginine levels had a strong effect on gene expression, but we didn’t expect the dietary manipulation to be equally impactful.”

The results may help explain connections between poor nutrition, aging and increased vulnerability to certain cancers and respiratory viruses. Arginine levels naturally decline with age, potentially diminishing the immune system’s ability to recognize abnormal or infected cells.

“Qiushuang’s findings illuminate how poor diet and aging — during which arginine levels naturally decline — could create the perfect storm for the initiation of colon cancer,” Tavazoie said. “Similarly, age-related arginine loss could partially contribute to the greater mortality caused by respiratory viruses.”

Advertisement

Because arginine is inexpensive and widely available, the researchers see potential for relatively rapid clinical exploration. Tavazoie noted that supplementation could be tested in patients already receiving immunotherapies or provided to high-risk groups facing viral exposure. “Considering that arginine is inexpensive and readily available, we hope that therapeutic and preventative studies could be undertaken soon,” he said.

The study does not claim that arginine alone constitutes a cure or complete preventive measure. Rather, it identifies a specific mechanism by which amino acid availability influences immune recognition and demonstrates that dietary or supplemental restoration can reverse some of the impairment in preclinical models. The work builds on years of investigation into metabolic influences on cancer biology and immune function.

Further research is examining whether adjusting levels of other amino acids produces beneficial effects in additional disease settings. The laboratory continues to explore how nutritional factors interact with genetic and immunological pathways.

Arginine occurs naturally in many protein sources, including meat, dairy, nuts and seeds, and the body synthesizes it as well. Over-the-counter supplements are already on the market for various uses. The new findings suggest a more targeted immunological rationale for considering arginine status in the context of cancer risk, viral susceptibility and aging.

Advertisement

The research received support in part from the Stavros Niarchos Foundation Institute for Global Infectious Disease Research at Rockefeller University and the Weill Cancer East Hub. By linking a simple nutrient to the production of a key immune signaling protein, the study opens a practical avenue for investigating whether modest nutritional interventions can enhance the body’s ability to identify and respond to internal and external threats.

Continue Reading

Business

Form 144 Airbnb For: 3 August

Published

on


Form 144 Airbnb For: 3 August

Continue Reading

Business

FAA clears smallest Boeing 737 Max to fly after years of delays

Published

on

FAA clears smallest Boeing 737 Max to fly after years of delays

The Federal Aviation Administration has certified the Boeing 737 Max 7, the smallest model in the bestselling family of aircraft, after nearly a decade of delays.

The agency on Monday said the approval “reflects years of sustained work to resolve complex technical issues and complete a thorough review of the airplane’s design and supporting safety analyses.”

Carriers including Southwest Airlines expected to fly the plane before the pandemic, but increased regulatory scrutiny following the fatal crashes of the in-service Max 8, in 2018 and 2019, other safety and manufacturing crises, and the redesign of an engine anti-icing system delayed certification.

Southwest said in a statement that “certification is an important step toward continuing to modernize our all-Boeing 737 fleet with upgraded interiors and more fuel-efficient aircraft to fit our Customers’ preferences and demand patterns.”

Advertisement

Airlines can finally start flying passengers soon after planes are certified, but it can take them months to work them into schedules.

Boeing said in a blog post Monday that it and Southwest are preparing for delivery of the first airplane.

“This important certification validates the rigor of our airplane’s design and recognizes the determination and resilience of our 737 MAX development team,” Stephanie Pope, president and CEO of Boeing Commercial Airplanes, said in a statement. 

The FAA said it “required the MAX-7 to incorporate key improvements … including updates to the flight-control software, flightcrew alerting system, and a redesigned engine anti-ice system,” adding that those changes prevent the engine from overheating.

Advertisement

The plane maker is also awaiting certification from the FAA of another long-delayed model, the 737 Max 10, which is the largest in the family and one that some carriers expected to start flying in 2020 as well as the manufacturer’s largest plane, the 777X.

Boeing has about 40 of the 737-7s and 737 Max 10s built and in inventory already, and the FAA approval could help the manufacturer bring in much-needed cash, Jefferies analyst Sheila Kahyaoglu said in a note Sunday. Boeing and other manufacturers receive the bulk of an airplane’s price when they hand it over to customers.

Boeing stock rose more than 6% in afternoon trading Monday.

The manufacturer, a top U.S. exporter, has been working to ramp up production of its 737 Maxes and 787 Dreamliners, key to its recovery after years of crisis since airlines and other customers pay the bulk of the aircraft’s price upon delivery. Boeing opened a new production line in Everett, Washington, in July for its 737 Max airplanes.

Advertisement

The company has been working to win back the trust of the FAA, and has made strides, including in mid-July, when the FAA said it could once again issue airworthiness certificates for its bestselling 737 Max aircraft and 787 Dreamliners. The agency stripped that from Boeing after the Max 8 crashes, which killed 346 people.

— CNBC’s Michele Luhn contributed to this report.

Continue Reading

Business

Amazon joins $3 trillion club as AI, cloud growth fuel stock rally

Published

on

Amazon joins $3 trillion club as AI, cloud growth fuel stock rally
Amazon’s market capitalisation surpassed $3 trillion for the first time on Monday as its shares rallied following strong earnings and signs that the AI boom is fueling demand for its highly profitable cloud-computing business.

The stock climbed 5.5% to a record $286.20, extending its year-to-date gain to more than 23%.

Shares of the Seattle-based e-commerce and cloud-computing giant jumped 15% on Friday after posting its strongest cloud growth in more than four years and lifting its annual capital-spending forecast.

Among the six “Magnificent Seven” companies that have reported so far, only Amazon and Microsoft have convinced investors that their AI investments are paying off. Tesla, Alphabet and Meta, meanwhile, faced a backlash after their heavy spending weighed on free cash flow last quarter.

Advertisement

Like other Wall Street tech giants, Amazon has invested billions of dollars in expanding its AI infrastructure. In April, it disclosed a new investment in Anthropic, following an earlier pledge to invest up to $50 billion in OpenAI.


Founded by Jeff Bezos in 1994, Amazon added another $1 trillion to its market value in just over two years after first reaching a $2 trillion valuation in June 2024.
Apple, Microsoft, Alphabet, and Nvidia are other companies that have reached a market value of $3 trillion in the past. Nvidia is currently the world’s largest company by market capitalisation, at close to $5 trillion.

Continue Reading

Trending

Copyright © 2025